Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans.
Ravindra KC, Vaidya VS, Wang Z, Federspiel JD, Virgen-Slane R, Everley RA, Grove JI, Stephens C, Ocana MF, Robles-Díaz M, Isabel Lucena M, Andrade RJ, Atallah E, Gerbes AL, Weber S, Cortez-Pinto H, Fowell AJ, Hussaini H, Bjornsson ES, Patel J, Stirnimann G, Verma S, Elsharkawy AM, Griffiths WJH, Hyde C, Dear JW, Aithal GP, Ramaiah SK. Ravindra KC, et al. Among authors: isabel lucena m. Nat Commun. 2023 Mar 3;14(1):1215. doi: 10.1038/s41467-023-36858-6. Nat Commun. 2023. PMID: 36869085 Free PMC article.
Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury.
Rodriguez-Diaz C, Taminiau B, García-García A, Cueto A, Robles-Díaz M, Ortega-Alonso A, Martín-Reyes F, Daube G, Sanabria-Cabrera J, Jimenez-Perez M, Isabel Lucena M, Andrade RJ, García-Fuentes E, García-Cortes M. Rodriguez-Diaz C, et al. Among authors: isabel lucena m. Pharmacol Res. 2022 Aug;182:106348. doi: 10.1016/j.phrs.2022.106348. Epub 2022 Jul 8. Pharmacol Res. 2022. PMID: 35817360 Free article.
Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy.
Ye H, Chen C, Wu H, Zheng K, Martín-Adrados B, Caparros E, Francés R, Nelson LJ, Gómez Del Moral M, Asensio I, Vaquero J, Bañares R, Ávila MA, Andrade RJ, Isabel Lucena M, Martínez-Chantar ML, Reeves HL, Masson S, Blumberg RS, Gracia-Sancho J, Nevzorova YA, Martínez-Naves E, Cubero FJ. Ye H, et al. Among authors: isabel lucena m. Cell Death Dis. 2022 Feb 10;13(2):143. doi: 10.1038/s41419-022-04580-8. Cell Death Dis. 2022. PMID: 35145060 Free PMC article.
[Tetrabamate and a benefit-risk ratio].
Isabel Lucena M, Andrade RJ, García-Ruiz E, Madurga M. Isabel Lucena M, et al. Med Clin (Barc). 2002 Apr 6;118(12):477. doi: 10.1016/s0025-7753(02)72422-6. Med Clin (Barc). 2002. PMID: 11958767 Spanish. No abstract available.
Cuando la creación de un consorcio proporciona respuestas útiles: experiencia de la Latin American DILI network (LATINDILIN).
Bessone F, Hernández N, Mendizábal M, Sánchez A, Paraná R, Arrese M, Tagle M, Girala M, Lizarzábal M, Carrera E, Brahm J, Contreras F, Méndez-Sánchez N, Santos G, Nunes V, Medina-Cáliz I, Parra-Martínez C, Sanz-Villanueva L, Isabel Lucena M, Andrade RJ. Bessone F, et al. Among authors: isabel lucena m. Clin Liver Dis (Hoboken). 2019 May 29;13(Suppl 1):S17-S23. doi: 10.1002/cld.840. eCollection 2019 May. Clin Liver Dis (Hoboken). 2019. PMID: 31333824 Free PMC article. Spanish. No abstract available.
When the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN).
Bessone F, Hernandez N, Mendizabal M, Sanchez A, Paraná R, Arrese M, Tagle M, Girala M, Lizarzabal M, Carrera E, Brahm J, Contreras F, Mendez-Sanchez N, Santos G, Nunes V, Medina-Caliz I, Parra-Martinez C, Sanz-Villanueva L, Isabel Lucena M, Andrade RJ. Bessone F, et al. Among authors: isabel lucena m. Clin Liver Dis (Hoboken). 2019 Mar 4;13(2):51-57. doi: 10.1002/cld.778. eCollection 2019 Feb. Clin Liver Dis (Hoboken). 2019. PMID: 31139356 Free PMC article. Review. No abstract available.